Vascular endothelial growth factor 2
US8206708B2 · kind B2 · utility
2Cited by
48References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2011 |
| Grant date | Jun 26, 2012 |
| Priority date | — |
| Expiry date | Apr 28, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.